Joinn Laboratories (China) Co Ltd
Company Profile
Business description
Joinn Laboratories (China) Co Ltd is a non-clinical contract research organization(CRO) focused on drug safety assessment. It operates in three segments: Non-clinical studies services include drug safety assessment, drug metabolism & pharmacokinetics (DMPK) studies, & pharmacology & efficacy studies; Clinical trial & related services segment provides early-stage services such as clinical CRO services, co-managed phase I clinical research units, & bioanalytical services, and: Sales of research models engages in the design, production, breeding, & sales of research models, currently including non-human primates and rodents. The majority is from the Non- Clinical studies services. Its geographical segments are China, the United States, and Other countries, of which the majority is from China.
Contact
A5 Rongjing East Street
Beijing Economic-Technological Development Area
Beijing100176
CHNT: +86 1067869966
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
2,652
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 7,561.70 | 142.70 | -1.85% |
CAC 40 | 6,894.56 | 205.86 | -2.90% |
DAX 40 | 19,654.01 | 626.25 | -3.09% |
Dow JONES (US) | 37,645.59 | 2,900.34 | -7.15% |
FTSE 100 | 7,707.96 | 202.57 | -2.56% |
HKSE | 20,264.49 | 136.81 | 0.68% |
NASDAQ | 15,267.91 | 1,282.69 | -7.75% |
Nikkei 225 | 31,714.03 | 1,298.55 | -3.93% |
NZX 50 Index | 11,806.55 | 84.89 | -0.71% |
S&P 500 | 4,982.77 | 79.48 | -1.57% |
S&P/ASX 200 | 7,375.00 | 135.00 | -1.80% |
SSE Composite Index | 3,186.81 | 41.26 | 1.31% |